Why the study?
Is the Val781Ile mutation in the skeletal muscle sodium channel a causative mutation for hyperkalemic periodic paralysis and cardiac dysrhythmia?
Is the Val781Ile mutation in the skeletal muscle sodium channel a causative mutation for hyperkalemic periodic paralysis and cardiac dysrhythmia?
The Val781Ile mutation, previously associated with hyperkalemic periodic paralysis and cardiac dysrhythmia, is likely a benign polymorphism rather than a pathogenic mutation.
Answers are grounded in this paper and cite their sources.
Val781Ile likely benign; challenges prior pathogenicity reports and leaves open confirmatory human studies.
Twenty different point mutations have been identified in the gene coding for the alpha subunit of the adult skeletal muscle sodium channel in families with hyperkalemic periodic paralysis, paramyotonia congenita, and the potassium-aggravated myotonias. One novel mutation (Val(781)Ile) was reported in an adopted boy with potassium-sensitive weakness and cardiac dysrhythmia. The confidence in establishing this rare amino acid substitution as a causative mutation was limited by the absence of family members for segregation analysis. Functional expression studies herein show that Val(781)Ile is most likely a benign polymorphism and not a disease-associated mutation.
No takes yet. Share an insight, caveat, or question.
Green et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: